Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Hung

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cognitive Neuropsychiatry|July 5, 2012
The role of cognitive biases and personality variables in subclinical delusional ideationMahesh Menon, Lena Catherine Quilty, John Anthony Zawadzki, et al.
Journal of Hazardous Materials|December 26, 2024
Health impacts of asphalt emissions: Examining neurological risks and the need for long-term exposure mitigationElham H Fini, Farideh Pahlavan, Natalie Ortiz Vega, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Reprogramming insulin receptor activation with a de novo agonist to overcome severe insulin resistanceAlbert Hung, Xinru Wang, Michael Gao, et al.
Molecular Cell|October 14, 2025
Tuning insulin receptor signaling using de novo-designed agonistsXinru Wang, Sarah Cardoso, Kai Cai, et al.
Research Square|January 10, 2024
Health phenome of Parkinson's patients reveals prominent mood-sleep clusterAbby Olsen, Joseph Locascio, Idil Tuncali, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Multimodal Digital Phenotyping of Behavior in a Neurology Clinic: Development of the Neurobooth Platform and the First Two Years of Data CollectionAdonay S Nunes, Siddharth Patel, Brandon Oubre, et al.
JAMA Neurology|December 25, 2013
Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial, Michael A Schwarzschild, Alberto Ascherio, et al.
JAMA|September 14, 2021
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial, Michael A Schwarzschild, Alberto Ascherio, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cognitive Neuropsychiatry|July 5, 2012
The role of cognitive biases and personality variables in subclinical delusional ideationMahesh Menon, Lena Catherine Quilty, John Anthony Zawadzki, et al.
Journal of Hazardous Materials|December 26, 2024
Health impacts of asphalt emissions: Examining neurological risks and the need for long-term exposure mitigationElham H Fini, Farideh Pahlavan, Natalie Ortiz Vega, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Reprogramming insulin receptor activation with a de novo agonist to overcome severe insulin resistanceAlbert Hung, Xinru Wang, Michael Gao, et al.
Molecular Cell|October 14, 2025
Tuning insulin receptor signaling using de novo-designed agonistsXinru Wang, Sarah Cardoso, Kai Cai, et al.
Research Square|January 10, 2024
Health phenome of Parkinson's patients reveals prominent mood-sleep clusterAbby Olsen, Joseph Locascio, Idil Tuncali, et al.
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
Multimodal Digital Phenotyping of Behavior in a Neurology Clinic: Development of the Neurobooth Platform and the First Two Years of Data CollectionAdonay S Nunes, Siddharth Patel, Brandon Oubre, et al.
JAMA Neurology|December 25, 2013
Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial, Michael A Schwarzschild, Alberto Ascherio, et al.
JAMA|September 14, 2021
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial, Michael A Schwarzschild, Alberto Ascherio, et al.
Pageof 2